SYS6055
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SYS6055, covering 2026-04-15 to 2026-04-15. Get the full timeline:
Most recent: Clinical Trial Update: Phase I Clinical Study to Evaluate SYS6055 Injection in Participants With Relapsed/Refractory B-Cell Malignancies [Phase 1]